[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Mr_X_onX Mr X
Mr X posts on X about atai life, $atai, lack of, filed the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.
Engagements: undefined #
- X Week XXX +1,641%
- X Month XXX -XX%
- X Months XXXXX +242%
- X Year XXXXX -XX%
Mentions: undefined #
Followers: XXX #
- X Week XXX +1.40%
- X Month XXX +2.90%
- X Months XXX +48%
CreatorRank: undefined #
Social Influence #
Social category influence stocks XXXXX%
Social topic influence atai life 28.57%, $atai 28.57%, lack of 14.29%, filed 14.29%, sec 14.29%, lets go 14.29%, breakthrough XXXXX%
Top assets mentioned ATAI Life Sciences (ATAI)
Top Social Posts #
Top posts by engagements in the last XX hours
"Conclusion The August XX 2025 Senate field hearing highlighted the VAs commitment to researching emerging therapies like psychedelics ketamine/esketamine and TMS while clarifying the lack of evidence for HBOT in treating PTSD or TBI. Key results include: Reinforced VA support for psychedelic research (12 studies new MDMA trial). Clear guidance against HBOT for mental health conditions based on current evidence. Increased visibility of evidence-based therapies like ketamine (49 facilities) and TMS (62 facilities). Public and Congressional engagement to separate fact from fiction and guide"
X Link @Mr_X_onX 2025-08-24T15:09Z XXX followers, XXX engagements
"$ATAI added AI reaserch program. $ATAI Life Sciences N.V. filed a Form 8-K with the SEC on September XX 2025. Phase 2a complete. open-label extension (OLE) study evaluating a two-dose induction regimen of BPL-003 (intranasal mebufotenin benzoate also known as 5-MeO-DMT) in patients with treatment-resistant depression (TRD). Expected phase X middle of 2026"
X Link @Mr_X_onX 2025-09-23T13:05Z XXX followers, XXX engagements
"$ATAI atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003 Underscoring its Potential in Treatment-Resistant Depression. Lets go up from here 🤞"
X Link @Mr_X_onX 2025-10-16T20:19Z XXX followers, XXX engagements